Tilray Brands Files 8-K with Financial Updates

Ticker: TLRY · Form: 8-K · Filed: 2024-04-09T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, operations, sec-filing

TL;DR

Tilray Brands dropped its latest 8-K on April 9th – check the financials!

AI Summary

On April 9, 2024, Tilray Brands, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, providing an update on the company's performance. The report confirms Tilray Brands, Inc. as the registrant, incorporated in Delaware with its principal executive offices in Leamington, Ontario.

Why It Matters

This filing provides investors with crucial, up-to-date financial information and operational details for Tilray Brands, Inc., enabling informed investment decisions.

Risk Assessment

Risk Level: medium — 8-K filings are routine disclosures, but the specific financial details within can reveal significant performance changes or strategic shifts that may impact the company's stock.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Tilray Brands, Inc.?

The primary purpose of this 8-K filing is to report on Tilray Brands, Inc.'s results of operations and financial condition, along with financial statements and exhibits.

When was this 8-K report filed with the SEC?

This 8-K report was filed with the SEC on April 9, 2024.

What is Tilray Brands, Inc.'s Central Index Key (CIK)?

Tilray Brands, Inc.'s Central Index Key (CIK) is 0001731348.

Where are Tilray Brands, Inc.'s principal executive offices located?

Tilray Brands, Inc.'s principal executive offices are located at 265 Talbot Street West, Leamington, Ontario, N8H 4H3.

What is the Standard Industrial Classification (SIC) code for Tilray Brands, Inc.?

The Standard Industrial Classification (SIC) code for Tilray Brands, Inc. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.

From the Filing

0001171843-24-001910.txt : 20240409 0001171843-24-001910.hdr.sgml : 20240409 20240409070018 ACCESSION NUMBER: 0001171843-24-001910 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240409 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 24831093 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 f8k_040924.htm FORM 8-K Form 8-K 0001731348 False 0001731348 2024-04-09 2024-04-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 8-K _________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  April 9, 2024 _______________________________ Tilray Brands, Inc. (Exact name of registrant as specified in its charter) _______________________________ Delaware 001-38594 82-4310622 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 265 Talbot Street West Leamington , Ontario N8H 4H3 (Address of Principal Executive Offices) (Zip Code) ( 844 ) 845-7291 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) _______________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.0001 per share TLRY The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐     Item 2.02. Results of Operations and Financial Condition. On April 9, 2024, Tilray Brands, Inc. (“Tilray”) issued a press release announcing financial results for its third quarter ended February 29, 2024. A copy of the press release is furnished herewith as Exhibit 99.1. The information in this current report on Form 8-K, including the press release attached as Exhibit 99.1 hereto, is being furnished, but shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that se

View on Read The Filing